Healio

Implantable 1-year CGM sensor can ‘effectively manage’ type 1 or type 2 diabetes

Adults with diabetes using an implantable 1-year continuous glucose monitoring sensor had a mean time in range of about 66% ...
Seeking Alpha

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes ...
Healio

Fully-implantable CGM receives FDA authorization for integration with insulin pumps

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing approval to allow the Eversense E3 CGM to be integrated with insulin delivery systems.
Nasdaq

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, ...
Business Wire

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...

Glucotrack plans US trial of implantable glucose monitor this year

Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...
Nasdaq

Eversense® CGM System Receives iCGM Designation by the US FDA

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...
equities

Senseonics Gets FDA Approval for First Long-Term Implantable Continuous Glucose Monitoring System

Over 30 million people—9.4% of the population—have diabetes in the US, according to the CDC’s 2017 National Diabetes Statistics Report. Over 7 million of those with diabetes are undiagnosed, and the ...
Benzinga.com

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Introduced in the late 1990s, continuous glucose monitoring (CGM) revolutionized diabetes care. Prior to CGM, home blood glucose monitoring (BGM) methodologies – which involve patients using a lancet ...
Medscape

FDA Approves First Implantable Continuous Glucose Monitor

The US Food and Drug Administration (FDA) has approved the first-ever implantable continuous glucose monitoring system, the Eversense CGM (Senseonics), for people aged 18 years and older with diabetes ...
BioWorld

Continuous glucose monitor (CGM), BioWorld MedTech

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...